E. Ohman J or Asset Management AB Has $2.57 Million Holdings in CVS Health Co. (NYSE:CVS)

E. Ohman J or Asset Management AB raised its holdings in CVS Health Co. (NYSE:CVS) by 14.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 57,350 shares of the pharmacy operator’s stock after purchasing an additional 7,070 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in CVS Health were worth $2,574,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of CVS. Tandem Capital Management Corp ADV acquired a new position in CVS Health during the 4th quarter worth about $1,002,000. Jennison Associates LLC bought a new position in shares of CVS Health in the fourth quarter worth about $14,099,000. Copeland Capital Management LLC bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $104,000. Avantra Family Wealth Inc. acquired a new stake in shares of CVS Health in the fourth quarter valued at approximately $506,000. Finally, Spire Wealth Management raised its position in CVS Health by 27.0% in the 4th quarter. Spire Wealth Management now owns 12,397 shares of the pharmacy operator’s stock worth $556,000 after purchasing an additional 2,634 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of NYSE CVS opened at $56.39 on Wednesday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The business’s 50 day moving average price is $51.16 and its two-hundred day moving average price is $56.09. The company has a market cap of $70.96 billion, a PE ratio of 14.31, a price-to-earnings-growth ratio of 0.62 and a beta of 0.61.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.21 EPS. On average, analysts predict that CVS Health Co. will post 5.14 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.72%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio is 67.51%.

Wall Street Analysts Forecast Growth

CVS has been the subject of several research reports. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Royal Bank of Canada lowered their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $60.00 to $66.00 in a research report on Monday, November 18th. Finally, UBS Group boosted their price objective on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, November 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $68.12.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.